Navigation Links
Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
Date:9/5/2012

1759,973* Includes share-based compensation as follows:Research and development

$

1,013

$

1,133

$

6,947

$

5,307General and administrative8357132,9262,511Total

$

1,848

$

1,846

$

9,873

$

7,818 Reconciliation of Selected GAAP Measures to Non-GAAP Measures (1)
(unaudited; in thousands, except per share data) 

Three Months EndedJune 30,20122011GAAP net loss$

(16,906)

$

(10,964)Adjustments:Research & development share-based compensation(2)1,0131,133General & administrative share-based compensation(2)8357131,8481,846Non-GAAP net loss$

(15,058)

$

(9,118)Non-GAAP net loss per share – basic and diluted$

(0.22)

$

(0.15)(1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to 
be considered in isolation or as a substitute for comparable GAAP measures and should be
read only in conjunction with our financial statements prepared in accordance with GAAP.(2) All share-based compensation was excluded for the non-GAAP analysis. Reconciliation of Selected GAAP Measures to Non-GAAP Measures (1)
(unaudited; in thousands, except per share data) 

Year Ended June 30,20122011GAAP net income (loss)$

11,986

$

(35,203)Adjustments:Research & development share-based compensation(2)6,9475,307General & administrative share-based compensation(2)2,9262,511Therapeutic discovery project tax grant, net(3)-(586)9,8737,232Non-GAAP net income (loss)$

21,859

$

(27,971)Non-GAAP net income (loss) per share Basic$

0.32

$

(0.47)Diluted$

0.30

$

(0.47)(1) This presentation includes non-GAAP measures. Our n
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
2. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
10. Luminex Corporation Reports First Quarter 2012 Results
11. Hospira Reports First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... MADISON, Wis. , July 24, 2014 /PRNewswire/ ... provides specialty and compounded pharmaceuticals, announced that it ... sensitivity information unique to each individual based upon ... now possible by understanding the interaction between a ... "We,re very excited to provide this ...
(Date:7/24/2014)... , Germany , and ... -- , Exclusive global license ... for SF3B1 mutations, including next-generation sequencing (NGS) gene panels, ... to be targeted by new test, indicate favorable prognosis ... syndromes  QIAGEN sees potential for developing companion ...
(Date:7/24/2014)... -- Abaxis, Inc. (NasdaqGS: ABAX ), a medical ... financial results for the first fiscal quarter ended June ... Revenues of $47.5 million, up 10% over last year,s ... 50% over last year,s comparable quarter. Revenues ... up 20% over last year,s comparable quarter. , ...
Breaking Medicine Technology:Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11
... Oct. 12, 2011 Reportlinker.com announces that ... in its catalogue: ... Region 2010-2014 ... the Peripheral Vascular Devices market in the ...
... (NYSE: BSX ) will webcast its conference call ... 2011 on Thursday, October 20, at 8:00 a.m. ET. ... becomes Boston Scientific,s Chief Executive Officer on October 17, and ... A live webcast of the conference call will be ...
Cached Medicine Technology:Peripheral Vascular Device Market in the APAC Region 2010-2014 2Boston Scientific To Webcast Conference Call Discussing Third Quarter 2011 Financial Results 2
(Date:7/26/2014)... July 26, 2014 According to the ... this is a comprehensive bodybuilding program that helps men ... anabolic steroids . The program also instructs men ... cardio. , Vkool reveals in its review that ... that can help men get ripped and jacked at ...
(Date:7/26/2014)... As the category creator and world leader ... Xoçai is to transform and improve individual ... products. One such unique element is XoVita™, a ... blueberries, an ingredient combination exclusive to Xoçai. This ... all of Xoçai products and provides a wide-ranging ...
(Date:7/25/2014)... 2014 PersonalInjurySolicitorsIreland, a legal claims ... people who have suffered from a variety of ... their new company, and a website, http://www.PersonalInjurySolicitorsIreland.com ... website explained, http://www.personalinjurysolicitorsireland.com/personal-injury-claims , the law firm ... the company is always on the client, and ...
(Date:7/25/2014)... In recent years, men have become more aware ... symptoms associated with age-related testosterone decline. Amid concerns about testosterone ... case study from Renew Man helps to shed ... using bioidentical hormones. , The case study centers around a ... himself beginning to feel the effects of age-related hormonal decline. ...
(Date:7/25/2014)... July 25, 2014 A federal judge ... in two DePuy Pinnacle hip lawsuits ( http://www.depuypinnacle-lawsuit.com/ ... the claims to go before a jury on September ... rendered on July 18th, U.S. District Judge Ed Kinkeade ... two Plaintiffs’ claims may proceed to trial against Johnson ...
Breaking Medicine News(10 mins):Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 2Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 2Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 4Health News:PersonalInjurySolicitorsIreland.com Announces the Launch of their New Company and Website 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 2Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 4
... NEW YORK, March 25 As Americans get ... it,s important for men with type 2,diabetes to ... low testosterone than,non-diabetic men., Listen to this ... Registered journalists can access video, audio, text, graphics ...
... In a ceremony,attended by Ohio,s physician leaders, ... of the most sweeping physician-insurance industry,contract reform bills ... law, which will take effect in ninety days, ... the contracting process,fairness in contracting, and a standardized ...
... of a prevention effort , , TUESDAY, March 25 (HealthDay ... to prevent cancer can often be overstated in certain ... a new report claims. , The review, published in ... of the National Cancer Institute , suggests that some ...
... A new study reviewing 75 group-randomized cancer trials over ... those studies used appropriate statistical methods to analyze the ... reported that interventions to prevent disease or reduce cancer ... have been. , More than a third of the ...
... NEW YORK, March 25 North American Insurance,Leaders, Inc. ... of a majority,of the common stock of NAO entitled ... voted against the proposal to consummate a business,combination, as ... Since NAO will not be able to complete ...
... China, March 25 /Xinhua-PRNewswire/ -- China Medicine,Corporation ... "the Company"),a leading developer and distributor of ... medicines (TCM), nutritional and,dietary supplements, medical devices, ... conduct a conference call at 9:00 a.m. ...
Cached Medicine News:Health News:Governor Strickland Signs House Bill 125 Into Law 2Health News:Some Cancer Trials Overstate Findings, Analysis Claims 2Health News:Some Cancer Trials Overstate Findings, Analysis Claims 3Health News:Review of group-based cancer trials reveals flaws in studies' design and analysis 2Health News:Review of group-based cancer trials reveals flaws in studies' design and analysis 3Health News:China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results 2Health News:China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results 3
The Volk 30D is designed to provide the practitioner a wide field of view with a short working distance. This lens is excellent for use with small pupils....
Provides exceptional resolution and fundus scanning capability. Excellent for small pupil diagnosis and treatment....
... The Macula Plus® ... detailed observation of the ... macula. Use it with ... for detecting choroidal neovascular ...
... Iris Diagnostics iQ200 Sprint Automated Urine Microscopy ... to the iQ200 Series. The analyzer uses ... to classify urine particles into 12 categories ... eliminates most technologist time used to prepare ...
Medicine Products: